The LPAR family triggers EMT and tumor progression through crosstalk with downstream signaling pathways, such as the NF-κB, MAPK/ERK, PI3K/AKT, TGF-β and Wnt/β-catenin pathways, and other oncogenic signaling pathways [43–45]. Here, TGFB1 is linked to neoplasm.